CLBT

CLBT

USD

Cellebrite DI Ltd. Ordinary Shares

$20.140+0.100 (0.499%)

实时价格

技术
Software - Infrastructure
以色列

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$20.040

最高价

$20.530

最低价

$20.010

成交量

0.13M

公司基本面

市值

4.8B

所属行业

Software - Infrastructure

国家/地区

Israel

交易统计

平均成交量

1.61M

交易所

NMS

货币

USD

52周价格范围

最低价 $10.245当前价 $20.140最高价 $26.3

AI分析报告

最后更新: 2025年5月4日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

CLBT (Cellebrite DI Ltd. Ordinary Shares): What's Happening and What to Watch

Stock Symbol: CLBT Generate Date: 2025-05-04 08:27:10

Let's break down what's been going on with Cellebrite stock lately, looking at the news, how the price has moved, and what some predictions are saying.

The Latest Buzz

The news flow around Cellebrite seems pretty positive right now. A big point is that Needham, an investment firm, has stuck with their "Buy" rating on the stock, and they're keeping a price target of $28. They've actually reiterated this target twice recently, once in late March and again in early April. That kind of repeated confidence from analysts can definitely catch investors' eyes.

Beyond the analyst view, the company also announced its first-ever "Digital Justice Awards," which sounds like a good bit of positive PR, highlighting their role in the digital investigation space. Filing their annual report is standard business, not really news unless something surprising was in it (which wasn't indicated here). So, overall, the news coming out leans favorable, especially with that analyst target hanging out there.

Checking the Price Chart

Looking back over the last few months, CLBT has had a bit of a rollercoaster ride. It started February up around the $23-$25 range, even touching $26 briefly. Then, things took a noticeable dip through the middle and end of February, dropping into the $19-$20 area. March saw it bounce around, even dipping below $17 at one point before starting to climb back.

More recently, in April and early May, the stock has been trading mostly between $18 and $20. It closed on May 2nd right around $20.14. So, after that earlier slide, it looks like the price has been trying to find its footing and has edged up slightly into the $20 territory.

Now, the AI prediction tool is forecasting upward movement for the next few days – predicting gains of 1.45% today, 3.08% tomorrow, and 4.20% the day after. If that plays out, it would continue this recent gentle upward trend, maybe even accelerating it a bit.

Putting It All Together: What Might This Mean?

Based on the positive analyst view, the recent upward nudge in price, and the AI's bullish short-term prediction, the situation for CLBT in the very near term seems to lean positive. The news sentiment is good, and the AI is calling for more gains.

So, what could an investor consider?

  • Potential Entry Idea: If you're thinking about getting in, the current price area, right around $20, looks interesting. The AI prediction suggests this level could be a launching point for a short-term move up. The AI's data even points to potential entry spots around $20.27 or $20.40, which are right there. It also notes the price is near a support level, which could offer a bit of a cushion.
  • Managing Risk: No investment is a sure thing, right? If you decide to jump in, having a plan for when to get out is smart. The AI suggests a stop-loss level around $18.12. This is below recent lows and could be a point to consider cutting losses if the price turns south unexpectedly.
  • Potential Upside: For taking profits, the AI gives a short-term target of $20.53. That's not a huge jump from the current price, but it aligns with a quick trading idea. Looking further out, the AI projects a potential target of $24.58, and the Needham analyst is way up at $28. These higher numbers show there's perceived room to grow if the positive momentum builds.

A Little Company Context

Remember, Cellebrite is a company focused on digital investigation tools. They help law enforcement and businesses handle digital evidence in various cases, from cybercrime to corporate security. This means their business is tied to the needs of these sectors. While the news and predictions look good right now, it's always worth keeping the company's fundamentals in mind. The data provided does flag a few things like a high P/E ratio (meaning the stock is expensive compared to its earnings), lower-than-expected growth, and high debt. These are factors that could weigh on the stock longer term, even if the short-term picture looks brighter due to sentiment and predictions.

This analysis is based purely on the data provided and is intended for informational purposes only. It's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

相关新闻

Analyst Upgrades

Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target

Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $28 price target.

查看更多
Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target
GlobeNewswire

10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners

查看更多
10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards
Analyst Upgrades

Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target

Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $28 price target.

查看更多
Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target
GlobeNewswire

Cellebrite Files its 2024 Annual Report on Form 20-F

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the

查看更多
Cellebrite Files its 2024 Annual Report on Form 20-F

AI预测Beta

AI建议

看涨

更新于: 2025年5月4日 06:24

看跌中性看涨

74.1% 置信度

风险与交易

风险等级3/5
中风险
适合于
适中
交易指南

入场点

$20.27

止盈点

$20.53

止损点

$18.12

关键因素

RSI 25.4表明超卖条件,暗示潜在的强力逆转
DMI显示看跌趋势(ADX:22.9,+DI:2.4,-DI:6.9),表明需谨慎
当前价格非常接近支撑水平$20.21,表明有强烈的买入机会
交易量是平均值的6.0倍(12,364),表明极强的买入压力
MACD -0.0401低于信号线-0.0273,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。